-0.05 (-0.319%)Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged
Telephone
Address
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 14.46 - 22.79
Trade Value (12mth)
US$9,470.00
1 week
4.76%
1 month
-3.52%
YTD
-28.97%
1 year
0%
All time high
22.79
EPS 3 yr Growth
1.70%
EBITDA Margin
25.70%
Operating Cashflow
$13,366m
Free Cash Flow Return
15.30%
ROIC
10.40%
Interest Coverage
21.70
Quick Ratio
1.20
Shares Outstanding (Fully Diluted)
1,747m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
15-Apr-26
Next Dividend Pay Date
25-May-26
Reporting Currency
CAD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| CAD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 4.42 | 10.51 | 5.22 | | | | ||
EPS (Fully Diluted) | $ | | | | | 4.4 | 10.46 | 5.2 | | | | ||
Growth | % | | | | | -13.8 | 137.7 | -50.4 | | | | ||
PE | X | | | | | N/A | N/A | 4.3 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 2.8 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
